Education
About Us
Working with TipRanks
Follow Us
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
ACL Analyst Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACL Stock 12 Month Forecast
Average Price Target
AU$3.43
▲(29.43% Upside)
| Highest Price TargetAU$3.85 | Average Price TargetAU$3.43 | Lowest Price TargetAU$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
AU$3
Hold
13.21%
Upside
Downgraded
12/01/25
Canaccord Genuity
AU$3.85
Buy
45.28%
Upside
Reiterated
10/24/25
Ord Minnett
AU$3.5
Buy
32.08%
Upside
Reiterated
08/27/25
Bank of America Securities
AU$3.4→AU$3.6
Buy
35.85%
Upside
Upgraded
06/23/25
Goldman Sachs
AU$3.3
Hold
24.53%
Upside
Initiated
04/03/25
Unknown Analyst
MacquarieNot Ranked
Macquarie
AU$3.15
Hold
18.87%
Upside
Reiterated
02/26/25
Citi
AU$4
Buy
50.94%
Upside
Reiterated
01/17/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
AU$3
Hold
13.21%
Upside
Downgraded
12/01/25
Canaccord Genuity
AU$3.85
Buy
45.28%
Upside
Reiterated
10/24/25
Ord Minnett
AU$3.5
Buy
32.08%
Upside
Reiterated
08/27/25
Bank of America Securities
AU$3.4→AU$3.6
Buy
35.85%
Upside
Upgraded
06/23/25
Goldman Sachs
AU$3.3
Hold
24.53%
Upside
Initiated
04/03/25
Unknown Analyst
MacquarieNot Ranked
Macquarie
AU$3.15
Hold
18.87%
Upside
Reiterated
02/26/25
Citi
AU$4
Buy
50.94%
Upside
Reiterated
01/17/25
Best Analysts Covering Australian Clinical Labs Ltd
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+3.46%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +3.46% per trade.
3 Months
xxx
Success Rate
4/6 ratings generated profit
Average Return
+10.05%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +10.05% per trade.
1 Year
Success Rate
3/6 ratings generated profit
Average Return
-1.15%
reiterated a buy rating 4 months ago
Copying Tom Godfrey's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.15% per trade.
2 Years
xxx
Success Rate
3/6 ratings generated profit
Average Return
-1.03%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACL Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
1
1
1
Buy
4
7
7
5
2
Hold
6
4
7
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
11
15
10
7
Each month's total comprises the sum of three months' worth of ratings.
ACL Financial Forecast
ACL Stock Forecast FAQ
What is AU:ACL’s average 12-month price target, according to analysts?
Based on analyst ratings, Australian Clinical Labs Ltd’s 12-month average price target is 3.43.
What is AU:ACL’s upside potential, based on the analysts’ average price target?
Australian Clinical Labs Ltd has 29.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Australian Clinical Labs Ltd a Buy, Sell or Hold?
Australian Clinical Labs Ltd has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Australian Clinical Labs Ltd’s share price target?
The average share price target for Australian Clinical Labs Ltd is 3.43. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$3.85 ,and the lowest forecast is AU$3.00. The average share price target represents 29.43% Increase from the current price of AU$2.65.
The highest analyst share price target is AU$3.85 ,and the lowest forecast is AU$3.00. The average share price target represents 29.43% Increase from the current price of AU$2.65.
What do analysts say about Australian Clinical Labs Ltd?
Australian Clinical Labs Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Australian Clinical Labs Ltd?
To buy shares of AU:ACL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.